SIS.TO Quote, Financials, Valuation and Earnings

Black Diamond Group has a net margin of 6.1% compared to Savaria's net margin of 7.28%. Savaria's return on equity of 8.29% beat Black Diamond Group's return on equity of 8.07%.

Savaria has a consensus price target of $24.33, signalling upside risk potential of 31.77%. On the other hand Black Diamond Group has an analysts' consensus of $12.54 which suggests that it could grow by 33.14%. Given that Black Diamond Group has higher upside potential than Savaria, analysts believe Black Diamond Group is more attractive than Savaria.

Savaria has a beta of 0.905, which suggesting that the stock is 9.473% less volatile than S&P 500. In comparison Black Diamond Group has a beta of 1.461, suggesting its more volatile than the S&P 500 by 46.092%.

Savaria has a quarterly dividend of $0.05 per share corresponding to a yield of 2.6%. Black Diamond Group offers a yield of 1.27% to investors and pays a quarterly dividend of $0.03 per share. Savaria pays 90.8% of its earnings as a dividend. Black Diamond Group pays out 15.84% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Savaria quarterly revenues are $213.6M, which are larger than Black Diamond Group quarterly revenues of $101.2M. Savaria's net income of $13M is higher than Black Diamond Group's net income of $7.4M. Notably, Savaria's price-to-earnings ratio is 31.11x while Black Diamond Group's PE ratio is 24.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Savaria is 1.64x versus 1.57x for Black Diamond Group. Usually stocks with elevated PS ratios are considered overvalued.

Beyond Medical Technologies has a net margin of 6.1% compared to Savaria's net margin of --. Savaria's return on equity of 8.29% beat Beyond Medical Technologies's return on equity of --.

Savaria has a consensus price target of $24.33, signalling upside risk potential of 31.77%. On the other hand Beyond Medical Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Savaria has higher upside potential than Beyond Medical Technologies, analysts believe Savaria is more attractive than Beyond Medical Technologies.

Savaria has a beta of 0.905, which suggesting that the stock is 9.473% less volatile than S&P 500. In comparison Beyond Medical Technologies has a beta of 3.116, suggesting its more volatile than the S&P 500 by 211.556%.

Savaria has a quarterly dividend of $0.05 per share corresponding to a yield of 2.6%. Beyond Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Savaria pays 90.8% of its earnings as a dividend. Beyond Medical Technologies pays out -- of its earnings as a dividend. Savaria's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Savaria quarterly revenues are $213.6M, which are larger than Beyond Medical Technologies quarterly revenues of --. Savaria's net income of $13M is higher than Beyond Medical Technologies's net income of -$100.2K. Notably, Savaria's price-to-earnings ratio is 31.11x while Beyond Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Savaria is 1.64x versus -- for Beyond Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Newlox Gold Ventures has a net margin of 6.1% compared to Savaria's net margin of -213.66%. Savaria's return on equity of 8.29% beat Newlox Gold Ventures's return on equity of -271.28%.

Savaria has a consensus price target of $24.33, signalling upside risk potential of 31.77%. On the other hand Newlox Gold Ventures has an analysts' consensus of -- which suggests that it could fall by --. Given that Savaria has higher upside potential than Newlox Gold Ventures, analysts believe Savaria is more attractive than Newlox Gold Ventures.

Savaria has a beta of 0.905, which suggesting that the stock is 9.473% less volatile than S&P 500. In comparison Newlox Gold Ventures has a beta of 2.160, suggesting its more volatile than the S&P 500 by 115.991%.

Savaria has a quarterly dividend of $0.05 per share corresponding to a yield of 2.6%. Newlox Gold Ventures offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Savaria pays 90.8% of its earnings as a dividend. Newlox Gold Ventures pays out -- of its earnings as a dividend. Savaria's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Savaria quarterly revenues are $213.6M, which are larger than Newlox Gold Ventures quarterly revenues of $395.5K. Savaria's net income of $13M is higher than Newlox Gold Ventures's net income of -$845.1K. Notably, Savaria's price-to-earnings ratio is 31.11x while Newlox Gold Ventures's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Savaria is 1.64x versus 8.44x for Newlox Gold Ventures. Usually stocks with elevated PS ratios are considered overvalued.

Sharc International Systems has a net margin of 6.1% compared to Savaria's net margin of -105.98%. Savaria's return on equity of 8.29% beat Sharc International Systems's return on equity of -160.68%.

Savaria has a consensus price target of $24.33, signalling upside risk potential of 31.77%. On the other hand Sharc International Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that Savaria has higher upside potential than Sharc International Systems, analysts believe Savaria is more attractive than Sharc International Systems.

Savaria has a beta of 0.905, which suggesting that the stock is 9.473% less volatile than S&P 500. In comparison Sharc International Systems has a beta of 0.557, suggesting its less volatile than the S&P 500 by 44.323%.

Savaria has a quarterly dividend of $0.05 per share corresponding to a yield of 2.6%. Sharc International Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Savaria pays 90.8% of its earnings as a dividend. Sharc International Systems pays out -- of its earnings as a dividend. Savaria's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Savaria quarterly revenues are $213.6M, which are larger than Sharc International Systems quarterly revenues of $785K. Savaria's net income of $13M is higher than Sharc International Systems's net income of -$832K. Notably, Savaria's price-to-earnings ratio is 31.11x while Sharc International Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Savaria is 1.64x versus 10.73x for Sharc International Systems. Usually stocks with elevated PS ratios are considered overvalued.